Chitosan-modified polymeric nanoparticles for the nose-to-brain drug delivery of paroxetine: an in vitro and in vivo evaluation
Nanoscale · 2025
DOI: 10.1039/d4nr04250f ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanoscale, 2025. Verfasst von Surbhi Sharma und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Jaypee Institute of Information Technology, Noida, UP, India. shweta.dang@jiit.ac.in. Hauptthemen laut MEDLINE: Chitosan, Paroxetine, Nanoparticles, Brain. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: Amity University.
Abstract (Originalsprache)
Chitosan-modified PLGA nanoparticles can increase the therapeutic potential of the paroxetine drug by increasing the targeted delivery through a cellular uptake mechanism. The mucoadhesive polymers enhance drug delivery via the intranasal route.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Jaypee Institute of Information Technology, Noida, UP, India. shweta.dang@jiit.ac.in.
- Institute of Nuclear Medicine and Allied Sciences, Defence Research and Development Organisation, Delhi, India.
Förderung
- Amity University
Zitieren
APA
Sharma, S., Gauba, P., Tyagi, A., & Dang, S. (2025). Chitosan-modified polymeric nanoparticles for the nose-to-brain drug delivery of paroxetine: an in vitro and in vivo evaluation. Nanoscale. https://doi.org/10.1039/d4nr04250f
Vancouver
Sharma S, Gauba P, Tyagi A, Dang S. Chitosan-modified polymeric nanoparticles for the nose-to-brain drug delivery of paroxetine: an in vitro and in vivo evaluation. Nanoscale. 2025. doi:10.1039/d4nr04250f
BibTeX
@article{Sharma2025,
author = {Sharma, Surbhi and Gauba, Pammi and Tyagi, Amit and Dang, Shweta},
title = {Chitosan-modified polymeric nanoparticles for the nose-to-brain drug delivery of paroxetine: an in vitro and in vivo evaluation},
journal = {Nanoscale},
year = {2025},
doi = {10.1039/d4nr04250f}
}
EUVIMED